SCCM Resource Library-April Journal Club Webcast: Spotlight on Pharmacy (2022)

Video Transcription

Video Summary

Hello and welcome to today's Journal Club Spotlight on Pharmacy webcast. This webcast focuses on three different studies. The first study looks at prophylactic melatonin for delirium in the intensive care unit. The second study compares atomidate and ketamine for emergency endotracheal intubation. And the third study examines intravenous milrinone for cerebral vasospasm in subarachnoid hemorrhage. Each study presents its objectives, methods, results, and conclusions. The first study found no statistically significant difference in delirium rates between patients receiving melatonin and those receiving a placebo. The second study found that ketamine resulted in a reduction in mortality at seven days compared to atomidate. The third study found that IV milrinone was associated with a lower rate of endovascular angioplasty and had some positive long-term neurological outcomes. Each presenter also discussed the strengths and limitations of their respective studies. Overall, these studies provide valuable insights into the use of melatonin, ketamine, and milrinone in critical care settings. However, further research is needed to fully evaluate the efficacy and safety of these interventions.

Asset Subtitle

Pharmacology, Neuroscience, 2022

Asset Caption

"The Journal Club: Spotlight on Pharmacy webcast series focuses on pharmacy topics. This event is held on the third Friday of each month and features lively discussion and in-depth presentations on the latest research.

Jessica Hu, PharmD
Wibrow B, Martinez FE, Myers E, et al. Prophylactic melatonin for delirium in intensive care (Pro-MEDIC): a randomized controlled trial. Intensive Care Med. 2022;48:414-425).

Lydia Ware, PharmD
Matchett G, Gasanova I, Riccio CA, et al. Etomidate versus ketamine for emergency endotracheal intubation: a randomized clinical trial. Intensive Care Med. 2022 Jan;48(1):78-91.

Alyssa Lear, PharmD
Lakhal K, Hivert A, Alexandre PL, et al. Intravenous milrinone for cerebral vasospasm in subarachnoid hemorrhage: the MILRISPASM controlled before-after study. Neurocrit Care. 2021 Dec;35(3):669-679.

Follow the conversation at #SCCMCPPJC."

Meta Tag

Content Type Webcast

Knowledge Area Pharmacology

Knowledge Area Neuroscience

Knowledge Level Intermediate

Knowledge Level Advanced

Membership Level Professional

Membership Level Select

Tag Analgesia and Sedation

Tag Delirium

Tag Subarachnoid Hemorrhage

Year 2022

Keywords

Pharmacy webcast

prophylactic melatonin

delirium

atomidate

ketamine

emergency endotracheal intubation

intravenous milrinone

cerebral vasospasm

subarachnoid hemorrhage

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.